Equity

9 Months Ended

Sep. 30, 2020

As of September 30, 2020 and December 31, 2019, we had 2 billion shares of common stock authorized. The following is a summary of Livent's common stock issued and outstanding:


	Issued	Treasury	Outstanding
Balance at December 31, 2019	146,085,696	(104,012)	145,981,684
Adjusted FMC RSU awards (1)	131,648	—	131,648
Livent RSU awards	123,511	—	123,511
Livent stock option awards	69,284	—	69,284
Purchases of treasury stock - deferred compensation plan	—	(3,610)	(3,610)


Balance at September 30, 2020	146,410,139	(107,622)	146,302,517

(1) See Note 12 to our consolidated and combined financial statements in Part II, Item 8 of our 2019 Annual Report on Form 10-K for more information on Adjusted FMC RSU awards held by FMC employees.

Summarized below is the roll forward of accumulated other comprehensive loss, net of tax.


(in Millions)	Foreign currency adjustments		Derivative Instruments (1)		Total
Accumulated other comprehensive loss, net of tax at December 31, 2019	$	(48.3)	—		$	(48.3)
Other comprehensive income/(loss) before reclassifications	1.4		(0.2)		1.2

Accumulated other comprehensive loss, net of tax at September 30, 2020	$	(46.9)	$	(0.2)	$	(47.1)


(in Millions)	Foreign currency adjustments		Derivative Instruments (1)		Total
Accumulated other comprehensive loss, net of tax at December 31, 2018	$	(48.0)	$	(1.2)	$	(49.2)
Other comprehensive (loss)/income before reclassifications	(1.9)		2.6		0.7
Amounts reclassified from accumulated other comprehensive loss	—		(1.1)		(1.1)
Accumulated other comprehensive (loss)/income, net of tax at September 30, 2019	$	(49.9)	$	0.3	$	(49.6)

(1) See Note 11 for more information.

Reclassifications of accumulated other comprehensive loss

The table below provides details about the reclassifications from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of operations for the period presented.


Details about Accumulated Other Comprehensive Loss Components	Amounts Reclassified from Accumulated Other Comprehensive Loss (1)								Affected Line Item in the Condensed Consolidated Statements of Operations
	Three Months Ended September 30,				Nine Months Ended September 30,
(in Millions)	2020		2019		2020		2019
Derivative instruments
Foreign currency contracts	$	(0.2)	$	(0.4)	$	(0.2)	$	(1.1)	Costs of sales and services

Total before tax	(0.2)		(0.4)		(0.2)		(1.1)

Amount included in net income (1)	$	(0.2)	$	(0.4)	$	(0.2)	$	(1.1)

(1) Provision for income taxes related to the reclassification was less than $0.1 million.

Dividends

For the three and nine months ended September 30, 2020 and 2019, we paid no dividends. We do not expect to pay any dividends in the foreseeable future.